XR651, a novel naphthacene-5,12-dione.
Bahl
S
S
London International Group, Research and Development, Cambridge, U.K.
Martin
S
S
Rawlins
P
P
Sadeghi
R
R
Smith
P M
PM
Steel
J
J
Shanu-Wilson
P
P
Wood
K A
KA
Wrigley
S K
SK
D000192:Actinomycetales / Q000737:chemistry / Q000145:classification / Q000648:ultrastructure; D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D015850:Interleukin-6 / Q000096:biosynthesis; D009682:Magnetic Resonance Spectroscopy; D008855:Microscopy, Electron, Scanning; D015394:Molecular Structure; D009279:Naphthacenes / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D014407:Tumor Cells, Cultured
D000900:Anti-Bacterial Agents; D007375:Interleukin-1; D015850:Interleukin-6; D009279:Naphthacenes; C105378:XR651